Novo Nordisk creates four R&D centres by shedding 400 jobs
Novo Nordisk will restructure its R&D operations through the increased investment made possible by laying off 400 members of staff.
Top Headlines
Global Industry News
-
Takeda to move US base to Boston
from in-PharmaTechnologist.com
-
Veeva launches single app to manage clinical trial data
from Outsourcing-Pharma.com
-
‘Revamped’ MannKind secures $105m licensing deal, plans Afrezza expansion
from in-PharmaTechnologist.com
-
Breaking the mold: Patient-centricity in psychiatric clinical trials
from Outsourcing-Pharma.com
Hot Topics
-
Oncology vaccine ensured 100% survival rate in lab studies
Cell & Gene Therapies
-
How the US-Mexico trade deal could impact the biologics market
Biosimilars
-
The third generation of large molecule drugs? Controlled-release biologics, says DelSiTech
Pipelines
-
Thermo Fisher expands bioprocessing with BD acquisition
Cell & Gene Therapies
